Clinical trials are of utmost importance to the Behcet’s community. There is no FDA approved treatment for Behcet’s Disease at this time. Through clinical trials, all stakeholders – patients, doctors, scientists and industry share the desire to contribute invaluable information about the benefits and safety of novel and existing therapies, providing doctors and patients with resources to select treatments. American Behcet’s Disease Association joins the global campaign for clinical trial registration and reporting led by AllTrials in an effort to improve transparency and access to trial data in order to assist our Behcet’s community and all patients.